Reglan Failure-To-Warn Claims Not Preempted, NJ Court Says

By Martin Bricketto (November 12, 2014, 5:54 PM EST) -- The New Jersey Appellate Division preserved patients' allegations that manufacturers of generic Reglan failed to adequately warn about neurological risks because the companies dragged their feet in updating the digestion medication's labeling, ruling Wednesday that federal law doesn't preempt the claims....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!